Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Chatbot-Delivered COVID-19 Vaccine Communication Message Preferences of Young Adults and Public Health Workers in Urban American Communities: Qualitative Study.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Source:
      Publisher: JMIR Publications Country of Publication: Canada NLM ID: 100959882 Publication Model: Electronic Cited Medium: Internet ISSN: 1438-8871 (Electronic) Linking ISSN: 14388871 NLM ISO Abbreviation: J Med Internet Res Subsets: MEDLINE
    • Publication Information:
      Publication: <2011- > : Toronto : JMIR Publications
      Original Publication: [Pittsburgh, PA? : s.n., 1999-
    • Subject Terms:
    • Abstract:
      Background: Automated conversational agents, or chatbots, have a role in reinforcing evidence-based guidance delivered through other media and offer an accessible, individually tailored channel for public engagement. In early-to-mid 2021, young adults and minority populations disproportionately affected by COVID-19 in the United States were more likely to be hesitant toward COVID-19 vaccines, citing concerns regarding vaccine safety and effectiveness. Successful chatbot communication requires purposive understanding of user needs.
      Objective: We aimed to review the acceptability of messages to be delivered by a chatbot named VIRA from Johns Hopkins University. The study investigated which message styles were preferred by young, urban-dwelling Americans as well as public health workers, since we anticipated that the chatbot would be used by the latter as a job aid.
      Methods: We conducted 4 web-based focus groups with 20 racially and ethnically diverse young adults aged 18-28 years and public health workers aged 25-61 years living in or near eastern-US cities. We tested 6 message styles, asking participants to select a preferred response style for a chatbot answering common questions about COVID-19 vaccines. We transcribed, coded, and categorized emerging themes within the discussions of message content, style, and framing.
      Results: Participants preferred messages that began with an empathetic reflection of a user concern and concluded with a straightforward, fact-supported response. Most participants disapproved of moralistic or reasoning-based appeals to get vaccinated, although public health workers felt that such strong statements appealing to communal responsibility were warranted. Responses tested with humor and testimonials did not appeal to the participants.
      Conclusions: To foster credibility, chatbots targeting young people with vaccine-related messaging should aim to build rapport with users by deploying empathic, reflective statements, followed by direct and comprehensive responses to user queries. Further studies are needed to inform the appropriate use of user-customized testimonials and humor in the context of chatbot communication.
      (©Rose Weeks, Lyra Cooper, Pooja Sangha, João Sedoc, Sydney White, Assaf Toledo, Shai Gretz, Dan Lahav, Nina Martin, Alexandra Michel, Jae Hyoung Lee, Noam Slonim, Naor Bar-Zeev. Originally published in the Journal of Medical Internet Research (https://www.jmir.org), 06.07.2022.)
    • References:
      Ann Intern Med. 2020 Dec 15;173(12):964-973. (PMID: 32886525)
      J Med Internet Res. 2020 Mar 6;22(3):e16235. (PMID: 32141837)
      Vaccine. 2021 Feb 12;39(7):1080-1086. (PMID: 33461833)
      J Health Commun. 2006;11(1):21-42. (PMID: 16546917)
      Acta Inform Med. 2020 Dec;28(4):241-247. (PMID: 33627924)
      Vaccine. 2015 Aug 14;33(34):4161-4. (PMID: 25896383)
      J Exp Psychol Appl. 2021 Oct 28;:. (PMID: 34726454)
      Soc Sci Med. 2021 Mar;272:113638. (PMID: 33414032)
      Health Educ Res. 2022 Mar 23;37(1):1-6. (PMID: 35048119)
      Hum Vaccin Immunother. 2013 Aug;9(8):1774-8. (PMID: 23733039)
      Front Public Health. 2021 Apr 23;9:645268. (PMID: 33968884)
      BMC Public Health. 2018 Jun 28;18(1):811. (PMID: 29954370)
      Front Digit Health. 2021 Nov 18;3:689999. (PMID: 34870266)
      J Med Syst. 2019 Apr 4;43(5):135. (PMID: 30949846)
      J Racial Ethn Health Disparities. 2022 Jun;9(3):886-898. (PMID: 33905110)
      J Public Health Manag Pract. 2022 Mar-Apr 01;28(2):E586-E594. (PMID: 34508051)
      Brain Behav Immun Health. 2021 Aug;15:100277. (PMID: 34036287)
      J Am Med Inform Assoc. 2022 Apr 13;29(5):1000-1010. (PMID: 35137107)
      PLoS Biol. 2009 May 26;7(5):e1000114. (PMID: 19478850)
      Vaccine. 2015 Aug 14;33(34):4176-9. (PMID: 25896376)
      Health Commun. 2012;27(1):10-8. (PMID: 22276999)
      Vaccine. 2020 Jun 26;38(31):4901-4908. (PMID: 32362529)
      JMIR Ment Health. 2017 Jun 06;4(2):e19. (PMID: 28588005)
      PLoS One. 2017 May 5;12(5):e0175799. (PMID: 28475576)
      MMWR Morb Mortal Wkly Rep. 2020 Aug 14;69(32):1049-1057. (PMID: 32790653)
      Vaccine. 2015 Aug 14;33(34):4204-11. (PMID: 25900132)
      NPJ Digit Med. 2020 May 4;3:65. (PMID: 32377576)
      Vaccine. 2022 Mar 15;40(12):1846-1854. (PMID: 35153096)
      J Health Commun. 2018;23(8):724-734. (PMID: 30160641)
      Trials. 2022 Feb 19;23(1):161. (PMID: 35183238)
      Expert Rev Vaccines. 2021 Aug;20(8):959-973. (PMID: 34192985)
      Vaccines (Basel). 2021 Apr 01;9(4):. (PMID: 33915695)
      J Med Internet Res. 2021 Feb 17;23(2):e25060. (PMID: 33484114)
      Vaccine. 2015 Aug 14;33(34):4212-4. (PMID: 25896382)
      Qual Health Res. 2019 Aug;29(10):1483-1496. (PMID: 30628545)
      JMIR Mhealth Uhealth. 2018 Nov 23;6(11):e12106. (PMID: 30470676)
      PLoS One. 2021 Dec 21;16(12):e0260731. (PMID: 34932583)
      Risk Anal. 1997 Feb;17(1):43-54. (PMID: 9131825)
    • Contributed Indexing:
      Keywords: AI; COVID-19; artificial intelligence; chatbots; conversational agent; digital health; health communication; infodemic; infodemiology; misinformation; natural language processing; online health information; public health; social media; user need; vaccination; vaccine communication; vaccine hesitancy
    • Accession Number:
      0 (COVID-19 Vaccines)
    • Publication Date:
      Date Created: 20220623 Date Completed: 20220708 Latest Revision: 20220804
    • Publication Date:
      20240513
    • Accession Number:
      PMC9301547
    • Accession Number:
      10.2196/38418
    • Accession Number:
      35737898